WO1999037750A1 - Method and device for cell lysis - Google Patents

Method and device for cell lysis Download PDF

Info

Publication number
WO1999037750A1
WO1999037750A1 PCT/FR1999/000105 FR9900105W WO9937750A1 WO 1999037750 A1 WO1999037750 A1 WO 1999037750A1 FR 9900105 W FR9900105 W FR 9900105W WO 9937750 A1 WO9937750 A1 WO 9937750A1
Authority
WO
WIPO (PCT)
Prior art keywords
pipe
lysis
agent
flow
meeting point
Prior art date
Application number
PCT/FR1999/000105
Other languages
French (fr)
Inventor
Michel Chevalier
Original Assignee
Aventis Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur filed Critical Aventis Pasteur
Priority to AU20604/99A priority Critical patent/AU756179B2/en
Priority to EP99900963A priority patent/EP1049766A1/en
Priority to NZ505865A priority patent/NZ505865A/en
Priority to US09/600,664 priority patent/US6664049B1/en
Priority to CA002319021A priority patent/CA2319021A1/en
Priority to JP2000528658A priority patent/JP2002500878A/en
Publication of WO1999037750A1 publication Critical patent/WO1999037750A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06Lysis of microorganisms

Definitions

  • the present invention relates to a method and a device for lysis of bacteria or eukaryotic cells, as well as extraction and purification of nucleic acids, and in particular plasmids, from bacteria or eukaryotic cells containing these plasmids.
  • plasmids of interest and in particular of plasmids into which a gene or a coding DNA sequence has been inserted, is carried out by multicopy of these plasmids in bacteria capable of producing a large number of these plasmids, and in particular in certain strains of Escherichia coli highly productive of plasmids and often already used in the laboratory or on an industrial scale.
  • the alkaline lysis technique which uses an alkaline lysis agent such as a sodium hydroxide + SDS preparation (sodium dodecyl sulfate), followed by neutralization with an acid agent, such as potassium acetate.
  • This neutralizing agent also has the effect of precipitating all of the bacterial constituents, including genomic DNA, the supernatant essentially containing plasmid DNA. The supernatant can then be separated from the precipitate by centrifugation or filtration (Birnboim Methods in Enzymology (1983) 100: 243).
  • the alkaline lysis technique is particularly recommended for lysing bacteria; but it can just as easily be used to lyse eukaryotic cells.
  • Such a method therefore implements a specific means, namely a static mixer, which replaces manual agitation of large volumes with continuous agitation over the entire length of the mixer.
  • a static mixer which replaces manual agitation of large volumes with continuous agitation over the entire length of the mixer.
  • the use of such a mixer in addition to requiring the purchase, maintenance and cleaning of the device, imposes a fixed period of contact with the lysis agent, with no practical possibility of controlling it or modulate it.
  • the stirring maintained in the mixer even if it is preferable to the poorly controlled stirring of discontinuous volumes, can cause breaks in, or degradations of cellular constituents and in particular of nucleic acids.
  • Another method also makes it possible to establish continuous lysis, but this time without using agitation means.
  • This process consists of (i) preparing a mixture of a bacterial suspension and an agent, such as lysozyme, allowing this mixture to incubate for approximately one hour in order to weaken the bacterial wall, then (ii) passing a flow of this mixture inside a pipe heated to high temperature (70-100 ° C).
  • high temperature 70-100 ° C
  • the action of heat promotes lysis.
  • the disadvantage of such a solution is that it requires heating means to 3 high temperatures and an adaptation of the temperature to the different special cases that may be encountered.
  • the present invention proposes to remedy these drawbacks and to provide a cell lysis process, applicable in particular to the extraction and purification of nucleic acids such as plasmids from bacteria or eukaryotic cells, which is capable of '' be implemented without manual intervention and under extremely economical conditions.
  • Another objective of the invention is to provide a method which makes it possible to control in an extremely precise manner the conditions and the duration of the lysis and of the extraction and this for all the cells present.
  • Another objective is to provide a method making it possible to establish substantially homogeneous lysis conditions for a population of cells.
  • Another objective is to provide a process capable of being implemented in a closed environment, free from contamination, which is an advantage for the pharmaceutical quality of the products sought, for example plasmids.
  • Another objective is to obtain a reduction in the duration of the cell / lysis agent contact, which is necessary to complete the lysis.
  • Another objective is to provide a device for implementing this method, a simple and inexpensive device.
  • Another objective is to provide on an industrial scale, plasmid preparations with a high yield and appreciably improved compared to that of the preparations which can be obtained according to the methods of the prior art.
  • the invention is based on the unexpected discovery that it is possible, by respecting a certain number of parameters, to ensure a homogeneous and controlled lysis of cells, and in particular of bacteria, by simple continuous mixing, in a usual pipe, of a suspension of cells with a lysis agent, despite the expected high viscosity, without using any of the means of the prior art such as a static mixer or high temperatures.
  • the invention therefore relates to a cell lysis process in which a liquid mixture of cells and a lysis agent is produced continuously, and 4 immediately causes this mixture to flow under a constant flow, inside a pipeline, the flow rate of this flow being adapted, as a function of the diameter and the length of the pipeline, so as to obtain a cell lysate substantially homogeneous with the outlet of said pipe. Obtaining a homogeneous lysate results in a sharp drop in turbidity and the appearance of a mixture transparent to the eye.
  • the pipeline has a small internal diameter so that the mixture forms almost instantly in a homogeneous manner, without the formation of separate liquid veins.
  • This diameter can be determined experimentally. In general, a diameter of the order of 1 cm or preferably less meets this definition, and a diameter of between 2 and 8 mm is preferred.
  • the diameter and the flow rate are elements of the process fixed in advance, it is just as possible to adapt the length of the pipe so as to obtain the desired effect. For example, for a given diameter and flow rate, it is enough to play on the length of the pipe, e.g., using a simple flexible pipe that is cut to the desired length.
  • the minimum length of the pipeline from the meeting point of the cell suspension and the lysis agent, which is necessary to travel to reach the lysis state, can be easily determined by simple observation through a pipeline transparent, from the reduction in the turbidity of the mixture until the appearance of a lysate transparent to the eye.
  • a pipe length of the order of 10 cm to a few meters is generally suitable.
  • One of the advantages of the invention consists in the homogeneity of the mixture during lysis (the duration of lysis is substantially identical for all bacteria); which ultimately allows a homogeneous lysate to be obtained. This is achieved by the appropriate choice of the parameters of the invention (diameter, and length of pipe, flow rate), without having to use stirring or heating means.
  • the mixture of cells and of lysis agent is produced by introducing, into the aforesaid pipeline, a flow of cells, for example of a 5 cell suspension, and a flow of a lysis agent solution, so that the flow of the flow of this mixture produces rapid homogenization, which is almost instantaneous, if using a reduced diameter pipeline.
  • the lysis agent can be a chemical agent, for example an alkaline agent, such as a sodium hydroxide solution + SDS, preferably a 0.2 M NaOH / 1% SDS mixture. It can also be a hypotonic solution compared to the cellular environment, intended to cause osmotic shock. In the case where the bacteria are simply transferred to a hypotonic solution, they have been treated beforehand so that their wall is weakened, by an agent such as lysozyme. Treatment with an alkaline agent is particularly suitable for bacterial lysis, while treatment with a hypotonic solution is particularly suitable for lysis of eukaryotic cells.
  • an alkaline lysis agent it is preferable to add to the lysate, a neutralizing agent. Indeed, the addition of this agent makes it possible to stop the degrading action linked to the alkaline agent, once a complete and homogeneous lysis has been obtained.
  • another advantage of the invention lies in exercising control over the period during which the cells are subjected to strongly alkaline pH conditions. This makes it possible to very easily implement the optimal duration conditions resulting in a total and homogeneous lysis while avoiding prolonging the action of the alkaline agent beyond the time necessary and sufficient to complete the lysis in order to avoid any action. deleterious in particular on DNA.
  • the neutralizing agent which is added to the lysate arriving at the end of the pipeline may preferably be sodium or potassium acetate, for example 3 M potassium acetate. It is advantageously chosen to so as to obtain a final pH close to 5.5 thanks to the addition of HCI 12N.
  • the aim pursued in fine consists eg in extracting plasmids
  • a precipitating agent sodium or potassium acetate can be used, for example 6
  • potassium acetate 3 M It is advantageously chosen so as to obtain a final pH close to 5.5 thanks to the addition of HCl 12N.
  • a precipitation agent such as sodium or potassium acetate also serves as a neutralizing agent, when the alkaline lysis technique is used.
  • the subject of the invention is also a method of extraction and / or purification of nucleic acids, in particular of plasmids, from a cell suspension, in which (i) the lysis method according to the invention in order to obtain a cell lysate and, continuously with the lysis process, (i) the cell lysate is treated with a precipitating and / or neutralizing agent, in order to obtain a preparation comprising a supernatant containing the plasmid DNA and a precipitated or flocculated phase containing the majority of cellular elements including genomic DNA.
  • a continuous mixture of a cell suspension and a liquid preparation (solution) of a lysis agent is produced, at a first determined meeting point, starting from from which a constant flow of said mixture is established in a pipe, in order to homogenize the mixture of the suspension and of the lysis agent, (ii) this mixture is maintained in this constant flow for a determined duration, and at the end of this duration (iii) adding, at a second determined meeting point, a solution of a precipitating agent; said duration being determined by the distance separating said first and second meeting points and by the speed of movement of the mixture (or linear flow) over this distance.
  • This plasmid extraction process can advantageously be implemented in the following way: (i) a flow of the cell suspension is established in a first channel;
  • a flow of the preparation obtained at the second meeting point is established, by mixing the cell lysate with the precipitation agent; and (vi) a preparation comprising a supernatant containing the plasmid DNA and a precipitated or flocculated phase containing the majority of the cellular elements including the genomic DNA is recovered at the outlet of the fifth channel.
  • step (vi) of recovery it is also possible to proceed, in any manner, with the separation of the supernatant from the precipitated or flocculated phase, preferably continuously from step (vi) of recovery.
  • the time required to obtain a complete and homogeneous lysis taking into account the usual proportions of suspension and of lysis agent, can be very substantially reduced and even less than one or more minutes, for example 5 min and even reduced to such low values. one or two seconds, contrasting with the ten minutes required in the prior art.
  • the proportion of flow rates, and therefore of mixed volumes preferably meets the following definitions: - bacterial suspension / lysis agent (for example sodium hydroxide mixture +
  • SDS between 1/4 and 3/4, and preferably of the order of 1/2
  • alkaline lysis agent / neutralizing acid agent preferably potassium acetate: between 1 and 2 and preferably of the order of 1, 3.
  • the concentration of the bacterial suspension is of the order of 170 grams (by wet weight of bacteria) / liter of a conventional buffer (for example Tris EDTA) + glucose.
  • a conventional buffer for example Tris EDTA
  • the cell suspension is stored at low temperature and directed at this same temperature in the pipe towards the meeting point with the lysis agent, this temperature preferably being of the order of 4 ° C.
  • the lysis agent can be maintained and transported at ambient temperature and the precipitating and / or neutralizing agent is preferably maintained at low temperature, such as 4 ° C. 9
  • the invention also relates to a device for implementing this process, characterized in that it comprises, from a source of cell suspension, such as a reservoir, a pipe allowing the establishment of a flow of cell suspension, from a source of a lysis agent such as a reservoir, a second line allowing the establishment of a flow of the lysis agent, said first and second lines leading to a first meeting point into which they open into one another, - a third pipe of small diameter and of determined length extending from said first meeting point, and means, such as pumping means, for the establishment of flows in said pipes; the length, the diameter and the flow rate in said third pipe being adapted so as to obtain a substantially homogeneous mixture resulting in a substantially homogeneous lysate.
  • the device may also comprise: from a source of neutralizing and / or precipitating agent, such as a reservoir, a fourth pipe leading to a second meeting point at the end of said third pipe so that the pipes open into one another, said third pipe having a length determined by the distance between said first meeting point and said second meeting point; from said second meeting point, a fifth small diameter pipe leading to recovery and / or separation means; and and means, such as pumping means, for establishing the flows in said fourth and fifth pipes.
  • a source of neutralizing and / or precipitating agent such as a reservoir
  • a fourth pipe leading to a second meeting point at the end of said third pipe so that the pipes open into one another said third pipe having a length determined by the distance between said first meeting point and said second meeting point
  • a fifth small diameter pipe leading to recovery and / or separation means and and means, such as pumping means, for establishing the flows in said fourth and fifth pipes.
  • all the pipes have small diameters as defined above.
  • the small diameters of said pipes can be identical or different.
  • the differences in diameter between pipes can be determined by the flow establishment means. 10
  • the means for establishing the flows can advantageously be pumps, preferably one or more peristaltic pumps making it possible to establish, in the various pipes, the flow rates, and therefore, taking into account the diameters of the pipes, the desired speeds.
  • the same pump for example, a peristaltic pump with several parallel channels, so as to ensure, even in the event of untimely variation of the pump flow rate , a constant proportionality between said flows.
  • the arrangement of the pipes according to the invention can be split, tripled or multiplied, preferably with flow establishment means, such as a pump, single or more pumps joined together so as to maintain, in all circumstances, a constant proportionality of the flows in each of the installations.
  • the outlet from one pipe to the other at a meeting point can be made at any angle. Generally it is preferred that one of the pipes opens substantially perpendicularly into the other but it is also possible to tilt the axes of the outlets.
  • the device according to the invention may include means for establishing and controlling temperatures so as to maintain the sources at the required temperatures.
  • the installation can be arranged so that the low temperature is maintained not only in the source but also in the first pipeline to the point where lysis begins.
  • An installation according to the invention makes it possible, for example, to treat a volume of bacterial suspension of the order of 1 to 5 liters per hour. 1 1
  • the mixture obtained downstream of the first meeting point exhibits great homogeneity throughout the duration of the treatment, as does the neutralized mixture downstream of the second meeting point, so that the separation means making it possible to separate, on the one hand , the plasmids remaining in solution, and, on the other hand, the other precipitated or flocculated cellular elements, work under constant conditions and contribute to the excellent reproducibility of the final purified plasmid preparation.
  • the bacterial suspension to be lysed is a suspension originating from a culture of an E. coli strain in which a plasmid such as the plasmid pUC18 in Tris EDTA buffer has been multiplied with a bacterial concentration of the order of 200 g (weight wet) per liter.
  • the sodium hydroxide-SDS mixture is a 0.2 M NaOH / 1% SDS mixture.
  • the potassium acetate solution used as a neutralizing agent is 3 M; pH 5.5.
  • the device shown in the figure comprises a first container 1 containing the bacterial suspension.
  • a first container 1 containing the bacterial suspension.
  • To this container are associated means for maintaining a temperature of the order of + 4 ° C. (not shown) and stirring means 2 making it possible to maintain the homogeneity of the suspension.
  • From the source 1 extends a flexible silicone pipe having an internal diameter of 2.06 mm and forming the first section of pipe 3.
  • the sodium hydroxide-SDS mixture is contained in a reservoir 4 from which extends a second pipe, 5 with an internal diameter of 3.17 mm and made of the same flexible material.
  • the pipe 3 opens perpendicularly into the pipe 5 so that at this location a mixture forms, causing rapid lysis of the bacteria.
  • From point 6 extends a third section of 12 pipe, 7 to point 8 forming the second meeting point, the length of pipe 7 being 0.8 meters.
  • This pipe 7 has an internal diameter of 7 mm (modular).
  • the potassium acetate solution is contained in a reservoir 9 from which extends a fourth pipe 10 also made of flexible material having an internal diameter of 2.79 mm opening into the pipe 7 at the meeting point 8, also perpendicular to line 7.
  • the container 9 is also associated with means for maintaining at low temperature + 4 ° C. From the second meeting point 8 extends a fifth pipe 11, formed subsequently by the pipe 7, this pipe 11 leading to a recovery tank 12.
  • diameters of the three pipes 3, 5 and 10 are in ratios such that the proportions of the internal sections of the pipes ensure, for the same speed of circulation of the liquids, the desired mixing proportions.
  • the flow rates thus obtained are respectively 160 ml / min in 7 and 244 ml / min in 11.
  • the bacteria are subjected to the action of the sodium hydroxide + SDS mixture throughout the duration of the path of the liquid in the pipe 7, between points 6 and 8. This duration, in the example chosen, is 15 sec.
  • a lysed preparation comprising two phases, namely a clear soluble phase containing the plasmids, substantially free of cellular element and an insoluble upper phase containing substantially the cellular elements. 13

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention concerns a method and a device for cell lysis which consists in continuously producing a liquid mixture of bacteria or eukaryiotic cells and a lysis agent, and in immediately causing said mixture to flow in a constant flux inside a pipe (7), the flow rate of said flux being adapted, according to the pipe (7) length and diameter, so as to obtain a substantially homogeneous lysate at said pipe (7) outlet.

Description

1 1
Procédé et dispositif de lyse cellulaireCell lysis method and device
La présente invention a trait à un procédé et un dispositif de lyse de bactéries ou de cellules eucaryotes, ainsi que d'extraction et de purification d'acides nucléiques, et notamment de plasmides, à partir de bactéries ou de cellules eucaryotes contenant ces plasmides.The present invention relates to a method and a device for lysis of bacteria or eukaryotic cells, as well as extraction and purification of nucleic acids, and in particular plasmids, from bacteria or eukaryotic cells containing these plasmids.
L'obtention de plasmides d'intérêt, et notamment de plasmides dans lesquels ont été insérés un gène ou une séquence codante d'ADN, est effectuée par multicopie de ces plasmides dans des bactéries aptes à produire un grand nombre de ces plasmides, et notamment dans certaines souches d'Escherichia coli hautement productives de plasmides et souvent déjà utilisées en laboratoire ou à l'échelle industrielle.The production of plasmids of interest, and in particular of plasmids into which a gene or a coding DNA sequence has been inserted, is carried out by multicopy of these plasmids in bacteria capable of producing a large number of these plasmids, and in particular in certain strains of Escherichia coli highly productive of plasmids and often already used in the laboratory or on an industrial scale.
L'une des applications qui demande une production importante d'un plasmide, à l'échelle industrielle, est la fabrication de médicaments ou vecteurs d'intérêt prophylactique ou thérapeutique à base d'un plasmide nu ou associé à des moyens de pénétration dans les cellules de l'hôte receveur. De telles applications sont décrites par exemple dans la demande de brevet WO 90/11092.One of the applications which requires significant production of a plasmid, on an industrial scale, is the manufacture of medicaments or vectors of prophylactic or therapeutic interest based on a naked plasmid or associated with means of penetration into the recipient host cells. Such applications are described for example in patent application WO 90/11092.
Il existe plusieurs techniques de lyse bactérienne permettant l'extraction des plasmides, suivie d'une séparation, et donc d'une purification de ces plasmides. La technique la plus couramment utilisée est la technique de lyse alcaline qui met en œuvre un agent de lyse alcalin tel qu'une préparation soude + SDS (dodécylsulfate de sodium), suivie d'une neutralisation par un agent acide, tel que de l'acétate de potassium. Cet agent de neutralisation a aussi pour effet de précipiter l'ensemble des constituants bactériens, dont I'ADN génomique, le surnageant contenant essentiellement I'ADN plasmidique. Le surnageant peut ensuite être séparé du précipitât par centrifugation ou filtration (Birnboim Methods in Enzymology (1983) 100 : 243). La technique de lyse alcaline est tout particulièrement recommandée pour lyser des bactéries ; mais elle peut tout aussi bien être utilisée pour lyser des cellules eucaryotes.There are several techniques of bacterial lysis allowing the extraction of the plasmids, followed by a separation, and therefore of a purification of these plasmids. The most commonly used technique is the alkaline lysis technique which uses an alkaline lysis agent such as a sodium hydroxide + SDS preparation (sodium dodecyl sulfate), followed by neutralization with an acid agent, such as potassium acetate. This neutralizing agent also has the effect of precipitating all of the bacterial constituents, including genomic DNA, the supernatant essentially containing plasmid DNA. The supernatant can then be separated from the precipitate by centrifugation or filtration (Birnboim Methods in Enzymology (1983) 100: 243). The alkaline lysis technique is particularly recommended for lysing bacteria; but it can just as easily be used to lyse eukaryotic cells.
Cette technique, qui convient à l'échelle du laboratoire, est pénible à mettre en œuvre à l'échelle industrielle car le lysat résultant de l'action de l'agent alcalin sur les bactéries constitue une suspension très visqueuse, de 2 sorte que le lysat en train de se former doit être homogénéisé par agitation. De même, après neutralisation à l'acide, une homogénéisation par agitation est nécessaire.This technique, which is suitable for the laboratory scale, is painful to implement on an industrial scale because the lysate resulting from the action of the alkaline agent on the bacteria constitutes a very viscous suspension, 2 so that the lysate being formed must be homogenized by agitation. Likewise, after neutralization with acid, homogenization by stirring is necessary.
Cette agitation est délicate et elle est effectuée généralement de façon manuelle, l'opérateur agitant doucement les bouteilles ou flacons contenant le milieu de lyse. Une agitation insuffisante procure une lyse de mauvaise qualité alors qu'une agitation excessive tend à morceler I'ADN génomique, qui se mélange par la suite aux plasmides. Dans les deux cas, on observe une diminution du rendement en ADN plasmidique. En conséquence, le tour de main de l'opérateur est un gage essentiel de réussite de l'opération.This stirring is delicate and it is generally carried out manually, the operator gently shaking the bottles or flasks containing the lysis medium. Insufficient agitation provides poor quality lysis while excessive agitation tends to fragment genomic DNA, which subsequently mixes with the plasmids. In both cases, a decrease in the yield of plasmid DNA is observed. Consequently, the operator's hand is an essential guarantee of the success of the operation.
Afin d'automatiser le procédé de lyse, on a déjà proposé, dans le document WO 97/23601, de faire passer, en continu, la suspension de cellules à lyser et une solution d'un agent de lyse à travers un mélangeur statique d'une longueur suffisante pour parachever la lyse. Le lysat qui en résulte peut ensuite être amené, par une canalisation, à un second mélangeur statique dans lequel pénètre également une solution d'un agent précipitant.In order to automate the lysis process, it has already been proposed, in document WO 97/23601, to pass, continuously, the suspension of cells to be lysed and a solution of a lysis agent through a static mixer. 'a sufficient length to complete the lysis. The resulting lysate can then be brought, by a pipe, to a second static mixer into which also enters a solution of a precipitating agent.
Un tel procédé met donc en œuvre un moyen spécifique, à savoir un mélangeur statique, qui remplace l'agitation manuelle de volumes importants par une agitation continue sur toute la longueur du mélangeur. L'utilisation d'un tel mélangeur, outre qu'elle demande l'achat, l'entretien et le nettoyage du dispositif, impose une durée fixe de mise en contact avec l'agent de lyse, sans possibilité pratique de la contrôler ou de la moduler. De plus, l'agitation entretenue dans le mélangeur, même si elle est préférable à l'agitation mal contrôlée de volumes discontinus, peut provoquer des cassures dans, ou des dégradations de constituants cellulaires et notamment d'acides nucléiques.Such a method therefore implements a specific means, namely a static mixer, which replaces manual agitation of large volumes with continuous agitation over the entire length of the mixer. The use of such a mixer, in addition to requiring the purchase, maintenance and cleaning of the device, imposes a fixed period of contact with the lysis agent, with no practical possibility of controlling it or modulate it. In addition, the stirring maintained in the mixer, even if it is preferable to the poorly controlled stirring of discontinuous volumes, can cause breaks in, or degradations of cellular constituents and in particular of nucleic acids.
Un autre procédé, décrit par exemple dans le document WO 96/36106, permet également d'établir une lyse en continu, mais cette fois sans utiliser de moyens d'agitation. Ce procédé consiste (i) à préparer un mélange d'une suspension bactérienne et d'un agent, tel que du lysozyme, à laisser incuber ce mélange pendant environ une heure afin de fragiliser la paroi bactérienne, puis (ii) à faire passer un flux de ce mélange à l'intérieur d'une canalisation chauffée à forte température (70-100°C). L'action de la chaleur favorise la lyse. L'inconvénient d'une telle solution est de nécessiter un moyen de chauffage à 3 des températures élevées et une adaptation de la température aux différents cas particuliers que l'on peut rencontrer.Another method, described for example in document WO 96/36106, also makes it possible to establish continuous lysis, but this time without using agitation means. This process consists of (i) preparing a mixture of a bacterial suspension and an agent, such as lysozyme, allowing this mixture to incubate for approximately one hour in order to weaken the bacterial wall, then (ii) passing a flow of this mixture inside a pipe heated to high temperature (70-100 ° C). The action of heat promotes lysis. The disadvantage of such a solution is that it requires heating means to 3 high temperatures and an adaptation of the temperature to the different special cases that may be encountered.
La présente invention se propose de remédier à ces inconvénients et de fournir un procédé de lyse cellulaire, applicable notamment à l'extraction et à la purification d'acides nucléiques tels que des plasmides à partir de bactéries ou de cellules eucaryotes, qui soit susceptible d'être mis en œuvre sans intervention manuelle et dans des conditions extrêmement économiques.The present invention proposes to remedy these drawbacks and to provide a cell lysis process, applicable in particular to the extraction and purification of nucleic acids such as plasmids from bacteria or eukaryotic cells, which is capable of '' be implemented without manual intervention and under extremely economical conditions.
Un autre objectif de l'invention est de fournir un procédé qui permet de contrôler de manière extrêmement précise les conditions et la durée de la lyse et de l'extraction et ceci pour la totalité des cellules en présence.Another objective of the invention is to provide a method which makes it possible to control in an extremely precise manner the conditions and the duration of the lysis and of the extraction and this for all the cells present.
Un autre objectif est de fournir un procédé permettant d'établir des conditions de lyse sensiblement homogène pour une population de cellules.Another objective is to provide a method making it possible to establish substantially homogeneous lysis conditions for a population of cells.
Un autre objectif est de fournir un procédé susceptible d'être mis en œuvre dans un milieu fermé, à l'abri des contaminations, ce qui est un avantage pour la qualité pharmaceutique des produits recherchés, par exemple des plasmides.Another objective is to provide a process capable of being implemented in a closed environment, free from contamination, which is an advantage for the pharmaceutical quality of the products sought, for example plasmids.
Un autre objectif est d'obtenir une réduction de la durée du contact cellules / agent de lyse, qui est nécessaire pour parachever la lyse.Another objective is to obtain a reduction in the duration of the cell / lysis agent contact, which is necessary to complete the lysis.
Un autre objectif est de fournir un dispositif pour la mise en œuvre de ce procédé, dispositif simple et peu onéreux.Another objective is to provide a device for implementing this method, a simple and inexpensive device.
Un autre objectif est de fournir à l'échelle industrielle, des préparations plasmidiques avec un rendement élevé et sensiblement amélioré par rapport à celui des préparations pouvant être obtenues selon les procédés de l'art antérieur. L'invention repose sur la découverte inattendue que l'on peut, moyennant le respect d'un certain nombre de paramètres, assurer une lyse homogène et contrôlée de cellules, et notamment de bactéries, par simple mélange en continu, dans une canalisation usuelle, d'une suspension de cellules avec un agent de lyse, malgré la viscosité importante attendue, sans utiliser aucun des moyens de l'art antérieur tel qu'un mélangeur statique ou des températures élevées.Another objective is to provide on an industrial scale, plasmid preparations with a high yield and appreciably improved compared to that of the preparations which can be obtained according to the methods of the prior art. The invention is based on the unexpected discovery that it is possible, by respecting a certain number of parameters, to ensure a homogeneous and controlled lysis of cells, and in particular of bacteria, by simple continuous mixing, in a usual pipe, of a suspension of cells with a lysis agent, despite the expected high viscosity, without using any of the means of the prior art such as a static mixer or high temperatures.
L'invention a donc pour objet un procédé de lyse cellulaire dans lequel on réalise, en continu, un mélange liquide de cellules et d'un agent de lyse, et l'on 4 fait immédiatement écouler ce mélange sous un flux constant, à l'intérieur d'une canalisation, le débit de ce flux étant adapté, en fonction du diamètre et de la longueur de la canalisation, de manière à obtenir un lysat cellulaire sensiblement homogène à la sortie de ladite canalisation. L'obtention d'un lysat homogène se traduit par une forte chute de la turbidité et l'apparition d'un mélange transparent à l'œil.The invention therefore relates to a cell lysis process in which a liquid mixture of cells and a lysis agent is produced continuously, and 4 immediately causes this mixture to flow under a constant flow, inside a pipeline, the flow rate of this flow being adapted, as a function of the diameter and the length of the pipeline, so as to obtain a cell lysate substantially homogeneous with the outlet of said pipe. Obtaining a homogeneous lysate results in a sharp drop in turbidity and the appearance of a mixture transparent to the eye.
De préférence, la canalisation présente un petit diamètre interne afin que le mélange se forme presque instantanément de manière homogène, sans qu'il se forme de veines liquides séparées. Ce diamètre peut être déterminé expérimentalement. En général, un diamètre de l'ordre de 1 cm ou de préférence inférieur répond à cette définition, et l'on préfère un diamètre compris entre 2 et 8 mm.Preferably, the pipeline has a small internal diameter so that the mixture forms almost instantly in a homogeneous manner, without the formation of separate liquid veins. This diameter can be determined experimentally. In general, a diameter of the order of 1 cm or preferably less meets this definition, and a diameter of between 2 and 8 mm is preferred.
On doit bien évidemment comprendre que si le diamètre et le débit du flux sont des éléments du procédé fixés à l'avance, on peut tout aussi bien adapter la longueur de la canalisation de manière à obtenir l'effet recherché. Par exemple pour un diamètre et un débit donné du flux, il suffit de jouer sur la longueur de la canalisation e.g., en utilisant une simple canalisation souple que l'on coupe à la longueur désirée.It should obviously be understood that if the diameter and the flow rate are elements of the process fixed in advance, it is just as possible to adapt the length of the pipe so as to obtain the desired effect. For example, for a given diameter and flow rate, it is enough to play on the length of the pipe, e.g., using a simple flexible pipe that is cut to the desired length.
La longueur minimale de la canalisation à partir du point de rencontre de la suspension cellulaire et de l'agent de lyse, qui est nécessaire de parcourir pour atteindre l'état de lyse, peut être facilement déterminée par simple observation au travers d'une canalisation transparente, de la diminution de la turbidité du mélange jusqu'à l'apparition d'un lysat transparent à l'œil. Une longueur de canalisation de l'ordre de 10 cm à, quelques mètres est en général convenable.The minimum length of the pipeline from the meeting point of the cell suspension and the lysis agent, which is necessary to travel to reach the lysis state, can be easily determined by simple observation through a pipeline transparent, from the reduction in the turbidity of the mixture until the appearance of a lysate transparent to the eye. A pipe length of the order of 10 cm to a few meters is generally suitable.
L'un des avantages de l'invention consiste dans l'homogénéité du mélange en cours de lyse (la durée de la lyse est sensiblement identique pour toutes les bactéries) ; ce qui permet d'obtenir in fine un lysat homogène. Ceci est réalisé par le choix convenable des paramètres de l'invention (diamètre, et longueur de canalisation, débit du flux), sans avoir recours à des moyens d'agitation ou de chauffage.One of the advantages of the invention consists in the homogeneity of the mixture during lysis (the duration of lysis is substantially identical for all bacteria); which ultimately allows a homogeneous lysate to be obtained. This is achieved by the appropriate choice of the parameters of the invention (diameter, and length of pipe, flow rate), without having to use stirring or heating means.
De préférence, le mélange de cellules et d'agent de lyse est réalisé en introduisant, dans la susdite canalisation, un flux de cellules, par exemple d'une 5 suspension cellulaire, et un flux d'une solution d'agent de lyse, de sorte que l'écoulement du flux de ce mélange produit une homogénéisation rapide, qui est presque instantanée, si on utilise une canalisation de diamètre réduit.Preferably, the mixture of cells and of lysis agent is produced by introducing, into the aforesaid pipeline, a flow of cells, for example of a 5 cell suspension, and a flow of a lysis agent solution, so that the flow of the flow of this mixture produces rapid homogenization, which is almost instantaneous, if using a reduced diameter pipeline.
L'agent de lyse peut être un agent chimique, par exemple un agent alcalin, tel qu'une solution soude + SDS, de préférence un mélange NaOH 0,2 M / SDS 1 %. Ce peut être aussi une solution hypotonique par rapport au milieu cellulaire, destinée à provoquer un choc osmotique. Dans le cas où les bactéries sont simplement transférées dans une solution hypotonique, elles ont été traitées au préalable de manière à ce que leur paroi soit fragilisée, par un agent tel que du lysozyme. Le traitement par un agent alcalin est particulièrement adapté à la lyse bactérienne, tandis que le traitement par une solution hypotonique convient tout particulièrement pour la lyse des cellules eucaryotes.The lysis agent can be a chemical agent, for example an alkaline agent, such as a sodium hydroxide solution + SDS, preferably a 0.2 M NaOH / 1% SDS mixture. It can also be a hypotonic solution compared to the cellular environment, intended to cause osmotic shock. In the case where the bacteria are simply transferred to a hypotonic solution, they have been treated beforehand so that their wall is weakened, by an agent such as lysozyme. Treatment with an alkaline agent is particularly suitable for bacterial lysis, while treatment with a hypotonic solution is particularly suitable for lysis of eukaryotic cells.
Dans le cas où l'on a utilisé un agent de lyse alcalin, on préfère ajouter au lysat, un agent de neutralisation. En effet, l'ajout de cet agent permet d'arrêter l'action de dégradation liée à l'agent alcalin, une fois obtenue une lyse totale et homogène. Dans ce dernier cas, un autre avantage de l'invention réside dans l'exercice du contrôle de la durée pendant laquelle les cellules sont soumises à des conditions de pH fortement alcalines. Ceci permet de mettre très facilement en œuvre les conditions de durée optimales aboutissant à une lyse totale et homogène en évitant de prolonger l'action de l'agent alcalin au-delà du temps nécessaire et suffisant pour parachever la lyse afin d'éviter toute action délétère en particulier sur I'ADN. L'agent neutralisant que l'on ajoute au lysat arrivant à l'extrémité de la canalisation peut être de préférence, de l'acétate de sodium ou de potassium, par exemple de l'acétate de potassium 3 M. Il est avantageusement choisi de façon à obtenir un pH final proche de 5,5 grâce à l'addition d'HCI 12N.In the case where an alkaline lysis agent has been used, it is preferable to add to the lysate, a neutralizing agent. Indeed, the addition of this agent makes it possible to stop the degrading action linked to the alkaline agent, once a complete and homogeneous lysis has been obtained. In the latter case, another advantage of the invention lies in exercising control over the period during which the cells are subjected to strongly alkaline pH conditions. This makes it possible to very easily implement the optimal duration conditions resulting in a total and homogeneous lysis while avoiding prolonging the action of the alkaline agent beyond the time necessary and sufficient to complete the lysis in order to avoid any action. deleterious in particular on DNA. The neutralizing agent which is added to the lysate arriving at the end of the pipeline may preferably be sodium or potassium acetate, for example 3 M potassium acetate. It is advantageously chosen to so as to obtain a final pH close to 5.5 thanks to the addition of HCI 12N.
D'autre part, si le but poursuivi in fine consiste e.g. à extraire des plasmides, il est souhaitable de séparer ces plasmides du reste des constituants cellulaires. Cette séparation est réalisée en précipitant ces constituants cellulaires, y compris I'ADN génomique, en ajoutant au lysat un agent précipitant ; les plasmides restant alors dans le surnageant. Comme agent de précipitation, on peut utiliser l'acétate de sodium ou de potassium, par 6On the other hand, if the aim pursued in fine consists eg in extracting plasmids, it is desirable to separate these plasmids from the rest of the cellular constituents. This separation is carried out by precipitating these cellular constituents, including genomic DNA, by adding a precipitating agent to the lysate; the plasmids then remaining in the supernatant. As the precipitating agent, sodium or potassium acetate can be used, for example 6
exemple de l'acétate de potassium 3 M. Il est avantageusement choisi de façon à obtenir un pH final proche de 5,5 grâce à l'addition d'HCI 12N.example of potassium acetate 3 M. It is advantageously chosen so as to obtain a final pH close to 5.5 thanks to the addition of HCl 12N.
Un agent de précipitation tel que l'acétate de sodium ou de potassium, sert aussi d'agent de neutralisation, lorsque l'on met en œuvre la technique de lyse alcaline.A precipitation agent such as sodium or potassium acetate also serves as a neutralizing agent, when the alkaline lysis technique is used.
L'invention a également pour objet un procédé d'extraction et/ou de purification d'acides nucléiques, notamment de plasmides, à partir d'une suspension cellulaire, dans lequel (i) on met en œuvre le procédé de lyse selon l'invention afin d'obtenir un lysat cellulaire et, en continu du procédé de lyse, (i) on traite le lysat cellulaire par un agent précipitant et/ou neutralisant, afin d'obtenir une préparation comportant un surnageant contenant I'ADN plasmidique et une phase précipitée ou floculée contenant la majorité des éléments cellulaires y compris I'ADN génomique. Pour ce faire, de manière avantageuse, (i) on réalise, en continu, un mélange d'une suspension cellulaire et d'une préparation liquide (solution) d'un agent de lyse, en un premier point de rencontre déterminé, à partir duquel on établit un flux constant dudit mélange dans une canalisation, pour homogénéiser le mélange de la suspension et de l'agent de lyse, (ii) on maintient ce mélange dans ce flux constant pendant une durée déterminée, et à la fin de cette durée (iii) on ajoute, en un second point de rencontre déterminé, une solution d'un agent précipitant ; ladite durée étant déterminée par la distance séparant lesdits premier et second points de rencontre et par la vitesse de déplacement du mélange (ou débit linéaire) sur cette distance. Une fois la précipitation effectuée, on procède, d'une façon quelconque, à la séparation des plasmides restés dans la surnageant d'avec le reste des éléments cellulaires précipités ou floculés.The subject of the invention is also a method of extraction and / or purification of nucleic acids, in particular of plasmids, from a cell suspension, in which (i) the lysis method according to the invention in order to obtain a cell lysate and, continuously with the lysis process, (i) the cell lysate is treated with a precipitating and / or neutralizing agent, in order to obtain a preparation comprising a supernatant containing the plasmid DNA and a precipitated or flocculated phase containing the majority of cellular elements including genomic DNA. To do this, advantageously, (i) a continuous mixture of a cell suspension and a liquid preparation (solution) of a lysis agent is produced, at a first determined meeting point, starting from from which a constant flow of said mixture is established in a pipe, in order to homogenize the mixture of the suspension and of the lysis agent, (ii) this mixture is maintained in this constant flow for a determined duration, and at the end of this duration (iii) adding, at a second determined meeting point, a solution of a precipitating agent; said duration being determined by the distance separating said first and second meeting points and by the speed of movement of the mixture (or linear flow) over this distance. Once the precipitation has been carried out, the plasmids remaining in the supernatant are separated in any way from the rest of the precipitated or flocculated cellular elements.
Ce procédé d'extraction plasmidique peut avantageusement être mis en œuvre de la façon suivante : (i) on établit un flux de la suspension cellulaire dans une première canalisation ;This plasmid extraction process can advantageously be implemented in the following way: (i) a flow of the cell suspension is established in a first channel;
(ii) on établit un flux de l'agent de lyse en solution dans une deuxième canalisation qui se jette dans la première canalisation (ou vice-versa) en un premier point de rencontre pour former une troisième canalisation ; 7(ii) establishing a flow of the lysis agent in solution in a second pipe which flows into the first pipe (or vice-versa) at a first meeting point to form a third pipe; 7
(iii) on établit un flux d'un agent précipitant dans une quatrième canalisation qui se jette dans la troisième canalisation (ou vice-versa) en un deuxième point de rencontre situé en aval du premier point de rencontre, pour former une cinquième canalisation ; (iv) on établit un flux du mélange cellules/agent de lyse réalisé au premier point de rencontre, dans la troisième canalisation (comprise entre le premier et le deuxième point de rencontre) à un débit linéaire adapté en fonction du diamètre et de la longueur de la troisième canalisation, de manière à permettre l'homogénéisation du mélange et l'obtention d'un lysat cellulaire sensiblement homogène au deuxième point de rencontre ; et(iii) establishing a flow of a precipitating agent in a fourth pipe which flows into the third pipe (or vice-versa) at a second meeting point located downstream of the first meeting point, to form a fifth pipe; (iv) a flow of the cell / lysis agent mixture produced at the first meeting point, in the third pipe (between the first and the second meeting point) is established at a linear flow rate adapted as a function of the diameter and the length the third pipe, so as to allow the homogenization of the mixture and the obtaining of a substantially homogeneous cell lysate at the second meeting point; and
(v) dans la cinquième canalisation, on établit un flux de la préparation obtenue au second point de rencontre, par mélange du lysat cellulaire avec l'agent de précipitation ; et (vi) on récupère à la sortie de la cinquième canalisation une préparation comprenant un surnageant contenant I'ADN plasmidique et une phase précipitée ou floculée contenant la majorité des éléments cellulaires y compris I'ADN génomique.(v) in the fifth pipe, a flow of the preparation obtained at the second meeting point is established, by mixing the cell lysate with the precipitation agent; and (vi) a preparation comprising a supernatant containing the plasmid DNA and a precipitated or flocculated phase containing the majority of the cellular elements including the genomic DNA is recovered at the outlet of the fifth channel.
Par la suite, on peut en outre procéder, de manière quelconque, à la séparation du surnageant d'avec la phase précipitée ou floculée, de préférence en continu de l'étape (vi) de récupération.Thereafter, it is also possible to proceed, in any manner, with the separation of the supernatant from the precipitated or flocculated phase, preferably continuously from step (vi) of recovery.
Le tableau suivant indique à titre d'exemple diverses conditions expérimentales ( longueur de canalisation, diamètre, débit, durée de mise en contact avec l'agent de lyse alcalin) qui permettent d'obtenir une lyse bactérienne complète et homogène, par la technique de lyse alcaline. Les concentrations bactériennes et d'agent de lyse restent identiques d'un essai à l'autre. Longueur de la Diamètre Débit Durée de mise en contact Canalisation avec l'agent de lyseThe following table indicates, by way of example, various experimental conditions (length of pipe, diameter, flow rate, duration of contact with the alkaline lysis agent) which make it possible to obtain a complete and homogeneous bacterial lysis, by the technique of alkaline lysis. The bacterial and lysis agent concentrations remain identical from one test to another. Length of Diameter Flow rate Contact time Pipe with lysis agent
28 cm 0,3 cm 160 ml/min 2 secondes28 cm 0.3 cm 160 ml / min 2 seconds
26 cm 0,7 cm 160 ml/min 15 secondes26 cm 0.7 cm 160 ml / min 15 seconds
85 cm + 0,7 cm 160 ml/min 4 minutes réservoir de 500 ml
Figure imgf000010_0001
85 cm + 0.7 cm 160 ml / min 4 minutes 500 ml tank
Figure imgf000010_0001
Le temps nécessaire pour obtenir une lyse complète et homogène, compte tenu des proportions usuelles de suspension et d'agent de lyse peut être très substantiellement réduit et même inférieur à une ou plusieurs minutes, par exemple 5 min et même ramenée à des valeurs aussi faibles qu'une ou deux secondes, contrastant avec la dizaine de minutes nécessaire dans l'art antérieur.The time required to obtain a complete and homogeneous lysis, taking into account the usual proportions of suspension and of lysis agent, can be very substantially reduced and even less than one or more minutes, for example 5 min and even reduced to such low values. one or two seconds, contrasting with the ten minutes required in the prior art.
On comprend également que l'on assure, grâce à l'invention, des conditions de lyse, de précipitation et/ou de neutralisation totalement homogènes dans le temps, sur l'ensemble de la suspension cellulaire que l'on fait couler à travers la canalisation.It is also understood that, by virtue of the invention, it provides completely homogeneous lysis, precipitation and / or neutralization conditions over time, over the entire cell suspension which is poured through the pipeline.
La proportion des débits, et donc des volumes mélangés répond de préférence aux définitions suivantes : - suspension bactérienne / agent de lyse (par exemple mélange soude +The proportion of flow rates, and therefore of mixed volumes, preferably meets the following definitions: - bacterial suspension / lysis agent (for example sodium hydroxide mixture +
SDS) : comprise entre 1/4 et 3/4, et de préférence de l'ordre de 1/2,SDS): between 1/4 and 3/4, and preferably of the order of 1/2,
- agent alcalin de lyse / agent acide neutralisant, de préférence acétate de potassium : comprise entre 1 et 2 et de préférence de l'ordre de 1 ,3.- alkaline lysis agent / neutralizing acid agent, preferably potassium acetate: between 1 and 2 and preferably of the order of 1, 3.
De préférence la concentration de la suspension bactérienne est de l'ordre de 170 grammes (en poids humide de bactéries) / litre d'un tampon classique (par exemple Tris EDTA) + glucose.Preferably the concentration of the bacterial suspension is of the order of 170 grams (by wet weight of bacteria) / liter of a conventional buffer (for example Tris EDTA) + glucose.
De préférence, la suspension cellulaire est conservée à basse température et dirigée à cette même température dans la canalisation vers le point de rencontre avec l'agent de lyse, cette température étant de préférence de l'ordre de 4°C. L'agent de lyse peut être maintenu et véhiculé à température ambiante et l'agent précipitant et/ou neutralisant est de préférence maintenu à basse température, telle que 4°C. 9Preferably, the cell suspension is stored at low temperature and directed at this same temperature in the pipe towards the meeting point with the lysis agent, this temperature preferably being of the order of 4 ° C. The lysis agent can be maintained and transported at ambient temperature and the precipitating and / or neutralizing agent is preferably maintained at low temperature, such as 4 ° C. 9
L'invention a également pour objet un dispositif pour la mise en œuvre de ce procédé, caractérisé en ce qu'il comporte, à partir d'une source de suspension cellulaire, telle qu'un réservoir, une canalisation permettant l'établissement d'un flux de suspension cellulaire, - à partir d'une source d'un agent de lyse telle qu'un réservoir, une deuxième canalisation permettant l'établissement d'un flux de l'agent de lyse, lesdites première et deuxième canalisations aboutissant à un premier point de rencontre dans lequel elles débouchent l'une dans l'autre, - une troisième canalisation de petit diamètre et de longueur déterminée s'étendant à partir dudit premier point de rencontre, et des moyens, tels que des moyens de pompage, pour l'établissement des flux dans lesdites canalisations ; la longueur, le diamètre et le débit dans ladite troisième canalisation étant adaptés de manière à obtenir un mélange sensiblement homogène aboutissant à un lysat sensiblement homogène.The invention also relates to a device for implementing this process, characterized in that it comprises, from a source of cell suspension, such as a reservoir, a pipe allowing the establishment of a flow of cell suspension, from a source of a lysis agent such as a reservoir, a second line allowing the establishment of a flow of the lysis agent, said first and second lines leading to a first meeting point into which they open into one another, - a third pipe of small diameter and of determined length extending from said first meeting point, and means, such as pumping means, for the establishment of flows in said pipes; the length, the diameter and the flow rate in said third pipe being adapted so as to obtain a substantially homogeneous mixture resulting in a substantially homogeneous lysate.
Le dispositif peut, en outre, comporter : à partir d'une source d'agent neutralisant et/ou précipitant, telle qu'un réservoir, une quatrième canalisation aboutissant à un second point de rencontre à l'extrémité de ladite troisième canalisation de façon que les canalisations débouchent l'une dans l'autre, ladite troisième canalisation ayant une longueur déterminée par la distance entre ledit premier point de rencontre et ledit second point de rencontre ; à partir dudit second point de rencontre, une cinquième canalisation de petit diamètre aboutissant à des moyens de récupération et/ou de séparation ; et et des moyens, tels que des moyens de pompage, pour l'établissement des flux dans lesdites quatrième et cinquième canalisations.The device may also comprise: from a source of neutralizing and / or precipitating agent, such as a reservoir, a fourth pipe leading to a second meeting point at the end of said third pipe so that the pipes open into one another, said third pipe having a length determined by the distance between said first meeting point and said second meeting point; from said second meeting point, a fifth small diameter pipe leading to recovery and / or separation means; and and means, such as pumping means, for establishing the flows in said fourth and fifth pipes.
De préférence toutes les canalisations ont de petits diamètres tels que définis précédemment.Preferably all the pipes have small diameters as defined above.
Les petits diamètres desdites canalisations peuvent être identiques ou différents. Les différences de diamètre entre canalisations peuvent être déterminées par les moyens d'établissement des flux. 10The small diameters of said pipes can be identical or different. The differences in diameter between pipes can be determined by the flow establishment means. 10
Les moyens d'établissement des flux peuvent avantageusement être des pompes, de préférence une ou plusieurs pompes péristaltiques permettant d'établir, dans les différentes canalisations, les débits, et donc, compte tenu des diamètres des canalisations, les vitesses désirées. De façon avantageuse on peut utiliser, pour l'établissement de deux ou plusieurs des flux, une même pompe, par exemple, une pompe péristaltique à plusieurs canaux parallèles, de façon à assurer, y compris en cas de variation intempestive de débit de la pompe, une proportionnalité constante entre lesdits flux. Bien entendu, si les quantités à traiter sont particulièrement importantes, l'agencement des canalisations selon l'invention peut être dédoublé, triplé ou multiplié, avec de préférence, des moyens d'établissement de flux, tels qu'une pompe, uniques ou plusieurs pompes solidarisées de façon à maintenir, en toute circonstance, une proportionnalité constante des flux dans chacune des installations.The means for establishing the flows can advantageously be pumps, preferably one or more peristaltic pumps making it possible to establish, in the various pipes, the flow rates, and therefore, taking into account the diameters of the pipes, the desired speeds. Advantageously, it is possible to use, for the establishment of two or more of the flows, the same pump, for example, a peristaltic pump with several parallel channels, so as to ensure, even in the event of untimely variation of the pump flow rate , a constant proportionality between said flows. Of course, if the quantities to be treated are particularly large, the arrangement of the pipes according to the invention can be split, tripled or multiplied, preferably with flow establishment means, such as a pump, single or more pumps joined together so as to maintain, in all circumstances, a constant proportionality of the flows in each of the installations.
Le débouché d'une canalisation dans l'autre au niveau d'un point de rencontre peut s'effectuer selon un angle quelconque. Généralement on préfère que l'une des canalisations débouche sensiblement perpendiculairement dans l'autre mais on peut également incliner les axes des débouchés.The outlet from one pipe to the other at a meeting point can be made at any angle. Generally it is preferred that one of the pipes opens substantially perpendicularly into the other but it is also possible to tilt the axes of the outlets.
De préférence on ne prévoit aucun moyen particulier d'homogénéisation tel que chicane ou obstacle dans la canalisation au niveau des points de rencontre ; ni de moyen de chauffage permettant d'atteindre de fortes températures (supérieures à 60°C). De façon avantageuse, le dispositif selon l'invention peut comporter des moyens d'établissement et de contrôle des températures de façon à maintenir les sources dans les températures requises. Notamment pour la suspension cellulaire, l'installation peut être agencée de façon que la basse température soit maintenue non seulement dans la source mais également dans la première canalisation jusqu'au point où débute la lyse.Preferably, no particular means of homogenization is provided such as a baffle or obstacle in the pipeline at the meeting points; nor heating means allowing to reach high temperatures (higher than 60 ° C). Advantageously, the device according to the invention may include means for establishing and controlling temperatures so as to maintain the sources at the required temperatures. In particular for the cell suspension, the installation can be arranged so that the low temperature is maintained not only in the source but also in the first pipeline to the point where lysis begins.
Une installation selon l'invention permet, par exemple, de traiter un volume de suspension bactérienne de l'ordre de 1 à 5 litres par heure. 1 1An installation according to the invention makes it possible, for example, to treat a volume of bacterial suspension of the order of 1 to 5 liters per hour. 1 1
Le mélange obtenu en aval du premier point de rencontre présente une grande homogénéité pendant toute la durée du traitement, de même que le mélange neutralisé en aval du deuxième point de rencontre, de sorte que les moyens de séparation permettant de séparer, d'une part, les plasmides restant en solution, et, d'autre part, les autres éléments cellulaires précipités ou floculés, travaillent dans des conditions constantes et contribuent à l'excellente reproductibilité de la préparation plasmidique purifiée finale.The mixture obtained downstream of the first meeting point exhibits great homogeneity throughout the duration of the treatment, as does the neutralized mixture downstream of the second meeting point, so that the separation means making it possible to separate, on the one hand , the plasmids remaining in solution, and, on the other hand, the other precipitated or flocculated cellular elements, work under constant conditions and contribute to the excellent reproducibility of the final purified plasmid preparation.
Par ailleurs on améliore notablement le rendement final qui peut dépasser 50 mg de plasmide pour 100 g de bactéries. D'autres avantages et caractéristiques de l'invention apparaîtront à la lecture de la description suivante, faite à titre d'exemple non limitatif et se référant au dessin annexé dans lequel la figure unique représente une vue schématique d'un dispositif de mise en œuvre du procédé selon l'invention.Furthermore, the final yield is significantly improved, which can exceed 50 mg of plasmid per 100 g of bacteria. Other advantages and characteristics of the invention will appear on reading the following description, given by way of nonlimiting example and referring to the appended drawing in which the single figure represents a schematic view of an implementation device of the method according to the invention.
La suspension bactérienne à lyser est une suspension provenant d'une culture d'une souche de E. coli dans laquelle a été multiplié un plasmide tel que le plasmide pUC18 en tampon Tris EDTA avec une concentration bactérienne de l'ordre de 200 g (poids humide) par litre.The bacterial suspension to be lysed is a suspension originating from a culture of an E. coli strain in which a plasmid such as the plasmid pUC18 in Tris EDTA buffer has been multiplied with a bacterial concentration of the order of 200 g (weight wet) per liter.
Le mélange soude-SDS est un mélange NaOH 0,2 M / 1 % SDS.The sodium hydroxide-SDS mixture is a 0.2 M NaOH / 1% SDS mixture.
La solution d'acétate de potassium utilisée comme agent neutralisant est à 3 M ; pH 5,5.The potassium acetate solution used as a neutralizing agent is 3 M; pH 5.5.
Le dispositif représenté sur la figure comprend un premier récipient 1 contenant la suspension bactérienne. A ce récipient sont associés des moyens de maintien à une température de l'ordre de + 4°C (non représentés) et des moyens d'agitation 2 permettant de maintenir l'homogénéité de la suspension. A partir de la source 1 s'étend une canalisation souple en silicone ayant un diamètre interne de 2,06 mm et formant le premier tronçon de canalisation 3.The device shown in the figure comprises a first container 1 containing the bacterial suspension. To this container are associated means for maintaining a temperature of the order of + 4 ° C. (not shown) and stirring means 2 making it possible to maintain the homogeneity of the suspension. From the source 1 extends a flexible silicone pipe having an internal diameter of 2.06 mm and forming the first section of pipe 3.
Le mélange soude-SDS est contenu dans un réservoir 4 à partir duquel s'étend une seconde canalisation, 5 de diamètre interne 3,17 mm et réalisée dans le même matériau souple. A l'emplacement 6 où se trouve le premier point de rencontre la canalisation 3 débouche perpendiculairement dans la canalisation 5 de sorte qu'à cet emplacement se forme un mélange provoquant la lyse rapide des bactéries. A partir du point 6 s'étend un troisième tronçon de 12 canalisation, 7 jusqu'au point 8 formant le second point de rencontre, la longueur de la canalisation 7 étant de 0,8 mètres. Cette canalisation 7 présente un diamètre interne de 7 mm (modulable).The sodium hydroxide-SDS mixture is contained in a reservoir 4 from which extends a second pipe, 5 with an internal diameter of 3.17 mm and made of the same flexible material. At the location 6 where the first meeting point is located, the pipe 3 opens perpendicularly into the pipe 5 so that at this location a mixture forms, causing rapid lysis of the bacteria. From point 6 extends a third section of 12 pipe, 7 to point 8 forming the second meeting point, the length of pipe 7 being 0.8 meters. This pipe 7 has an internal diameter of 7 mm (modular).
La solution d'acétate de potassium est contenue dans un réservoir 9 à partir duquel s'étend une quatrième canalisation 10 également en matière souple ayant un diamètre interne de 2,79 mm débouchant dans la canalisation 7 au point de rencontre 8, également perpendiculairement à la canalisation 7.The potassium acetate solution is contained in a reservoir 9 from which extends a fourth pipe 10 also made of flexible material having an internal diameter of 2.79 mm opening into the pipe 7 at the meeting point 8, also perpendicular to line 7.
Le récipient 9 est associé également à des moyens de maintien à basse température + 4°C. A partir du second point de rencontre 8 s'étend une cinquième canalisation 11 , formée par la suite de la canalisation 7, cette canalisation 11 aboutissant à un réservoir de récupération 12.The container 9 is also associated with means for maintaining at low temperature + 4 ° C. From the second meeting point 8 extends a fifth pipe 11, formed subsequently by the pipe 7, this pipe 11 leading to a recovery tank 12.
On comprend que les diamètres des trois canalisations 3, 5 et 10 sont dans des rapports tels que les proportions des sections internes des canalisations assurent, pour une même vitesse de circulation des liquides, les proportions de mélange souhaitées.It is understood that the diameters of the three pipes 3, 5 and 10 are in ratios such that the proportions of the internal sections of the pipes ensure, for the same speed of circulation of the liquids, the desired mixing proportions.
En conséquence les canalisations souples 3, 5 et 10 peuvent passer à travers une pompe péristaltique unique 13 dont la partie rotative 14 assure l'établissement des flux dans les susdites proportions dans les trois canalisations 3, 5 et 10.Consequently, the flexible pipes 3, 5 and 10 can pass through a single peristaltic pump 13, the rotary part 14 of which ensures the establishment of flows in the above proportions in the three pipes 3, 5 and 10.
L'établissement des débits dans les proportions souhaitées dans les canalisations 3, 5 et 10 détermine bien entendu la valeur des débits en aval dans les canalisations 7, et 11.The establishment of the flow rates in the desired proportions in the pipes 3, 5 and 10 of course determines the value of the flow rates downstream in the pipes 7, and 11.
Les débits ainsi obtenus sont respectivement de 160 ml/min dans 7 et 244 ml/min dans 11.The flow rates thus obtained are respectively 160 ml / min in 7 and 244 ml / min in 11.
Les bactéries sont soumises à l'action du mélange soude + SDS pendant toute la durée du trajet du liquide dans la canalisation 7, entre les points 6 et 8. Cette durée, dans l'exemple choisi, est de 15 sec.The bacteria are subjected to the action of the sodium hydroxide + SDS mixture throughout the duration of the path of the liquid in the pipe 7, between points 6 and 8. This duration, in the example chosen, is 15 sec.
On obtient finalement, dans le récipient de récupération 12, une préparation lysée comprenant deux phases, à savoir une phase soluble claire contenant les plasmides, sensiblement exempte d'élément cellulaire et une phase supérieure insoluble contenant sensiblement les éléments cellulaires. 13Finally, in the recovery container 12, a lysed preparation is obtained comprising two phases, namely a clear soluble phase containing the plasmids, substantially free of cellular element and an insoluble upper phase containing substantially the cellular elements. 13
La séparation de ces deux phases est effectuée ensuite par des techniques classiques de filtration ou de centrifugation et la purification des plasmides peut encore être poursuivie selon les méthodes usuelles.The separation of these two phases is then carried out by conventional filtration or centrifugation techniques and the purification of the plasmids can still be continued according to the usual methods.
A titre de vérification on a procédé à une électrophorèse comparative des solutions de plasmide obtenues après lyse alcaline, soit en flux continu (comme décrit dans l'exemple ci-dessus) soit par agitation manuelle pendant 10 min (les quantités de bactéries utilisées dans les deux cas étaient similaires). La révélation du gel d'électrophorèse met en évidence la supériorité du procédé en continu dans la mesure où la teneur en plasmides est accrue et celle des impuretés plus faible. By way of verification, a comparative electrophoresis was carried out of the plasmid solutions obtained after alkaline lysis, either in continuous flow (as described in the example above) or by manual stirring for 10 min (the amounts of bacteria used in the two cases were similar). The revelation of the electrophoresis gel highlights the superiority of the continuous process in that the plasmid content is increased and that of the impurities lower.

Claims

14REVENDICATIONS 14 CLAIMS
1. Procédé de lyse cellulaire selon lequel on réalise, en continu, un mélange liquide de cellules et d'un agent de lyse, et l'on fait immédiatement écouler ce mélange sous flux constant à l'intérieur d'une canalisation, le débit de ce flux étant adapté, en fonction du diamètre et de la longueur de la canalisation, de manière à obtenir un lysat cellulaire sensiblement homogène à la sortie de ladite canalisation.1. Cell lysis method according to which a liquid mixture of cells and a lysis agent is produced continuously, and this mixture is immediately made to flow under constant flow inside a pipe, the flow rate this flow being adapted, depending on the diameter and the length of the pipe, so as to obtain a substantially homogeneous cell lysate at the outlet of said pipe.
2. Procédé selon la revendication 1 , dans lequel la canalisation présente un diamètre réduit facilitant l'homogénéisation très rapide du mélange.2. Method according to claim 1, wherein the pipeline has a reduced diameter facilitating very rapid homogenization of the mixture.
3. Procédé selon l'une des revendications 1 et 2, dans lequel ledit petit diamètre est de l'ordre de 1 cm ou inférieur.3. Method according to one of claims 1 and 2, wherein said small diameter is of the order of 1 cm or less.
4. Procédé selon la revendication 3, dans lequel ledit petit diamètre est 2 à 8 mm.4. The method of claim 3, wherein said small diameter is 2 to 8 mm.
5. Procédé selon l'une des revendications 1 à 4, dans lequel le mélange de cellules et d'agent de lyse est réalisé en introduisant, dans la susdite canalisation, un flux d'une suspension de cellules et un flux d'une solution d'agent de lyse.5. Method according to one of claims 1 to 4, wherein the mixture of cells and lysis agent is carried out by introducing, into the said pipe, a flow of a suspension of cells and a flow of a solution lysis agent.
6. Procédé selon l'une des revendications 1 à 5, dans lequel l'agent de lyse est de nature alcaline.6. Method according to one of claims 1 to 5, wherein the lysis agent is of alkaline nature.
7. Procédé selon la revendication 6, caractérisé en ce que l'agent de lyse est un mélange soude/SDS.7. Method according to claim 6, characterized in that the lysis agent is a sodium hydroxide / SDS mixture.
8. Procédé selon la revendication 6 ou 7, dans lequel on ajoute un agent neutralisant au lysat cellulaire arrivant à l'extrémité de la canalisation. 158. The method of claim 6 or 7, wherein a neutralizing agent is added to the cell lysate arriving at the end of the pipeline. 15
9. Procédé selon la revendication 8, dans lequel l'agent neutralisant est de l'acétate de sodium ou de potassium.9. The method of claim 8, wherein the neutralizing agent is sodium or potassium acetate.
10. Procédé selon l'une des revendications 1 à 5, dans lequel l'agent de lyse est une solution hypotonique.10. Method according to one of claims 1 to 5, wherein the lysis agent is a hypotonic solution.
11. Procédé d'extraction d'ADN plasmidique à partir de cellules contenant ledit ADN, dans lequel (i) on met en œuvre un procédé de lyse selon l'une des revendications 1 à 7 et 10 afin d'obtenir un lysat cellulaire, et en continu du procédé de lyse, (ii) on traite le lysat cellulaire par un agent précipitant et/ou neutralisant, afin d'obtenir une préparation comportant un surnageant contenant I'ADN plasmidique et une phase précipitée ou floculée contenant la majorité des éléments cellulaires, y compris I'ADN génomique.11. Method for extracting plasmid DNA from cells containing said DNA, in which (i) a lysis method according to one of claims 1 to 7 and 10 is used in order to obtain a cell lysate, and continuously the lysis process, (ii) the cell lysate is treated with a precipitating and / or neutralizing agent, in order to obtain a preparation comprising a supernatant containing the plasmid DNA and a precipitated or flocculated phase containing the majority of the elements cells, including genomic DNA.
12. Procédé d'extraction selon la revendication 1 1 , dans lequel :12. Extraction method according to claim 1 1, in which:
(i) on établit un flux de la suspension cellulaire dans une première canalisation ;(i) a flow of the cell suspension is established in a first channel;
(ii) on établit un flux d'un agent de lyse dans une deuxième canalisation qui se jette dans la première canalisation (ou vice-versa) en un premier point de rencontre pour former une troisième canalisation ;(ii) a flow of a lysis agent is established in a second pipe which flows into the first pipe (or vice versa) at a first meeting point to form a third pipe;
(iii) on établit un flux d'un agent précipitant dans une quatrième canalisation qui se jette dans la troisième canalisation (ou vice- versa) en un deuxième point de rencontre situé en aval du premier point de rencontre, pour former une cinquième canalisation ;(iii) a flow of a precipitating agent is established in a fourth pipe which flows into the third pipe (or vice versa) at a second meeting point located downstream of the first meeting point, to form a fifth pipe;
(iv) on établit un flux du mélange cellules / agent de lyse réalisé au premier point de rencontre, dans la troisième canalisation (comprise entre le premier et le deuxième point de rencontre) à un débit adapté en fonction du diamètre et de la longueur de la troisième canalisation, de manière à permettre l'homogénéisation du mélange et l'obtention d'un lysat cellulaire sensiblement homogène au deuxième point de rencontre ; et 16(iv) a flow of the cell / lysis agent mixture produced at the first meeting point, in the third pipe (between the first and the second meeting point) is established at a flow rate adapted as a function of the diameter and the length of the third channeling, so as to allow the homogenization of the mixture and the obtaining of a substantially homogeneous cell lysate at the second meeting point; and 16
(v) dans la cinquième canalisation, on établit un flux de la préparation obtenue au second point de rencontre, par mélange du lysat cellulaire avec l'agent précipitant ; et (vi) on récupère à la sortie de la cinquième canalisation une préparation comportant un surnageant contenant I'ADN plasmidique et une phase précipitée ou floculée contenant la majorité des éléments cellulaires, y compris I'ADN génomique.(v) in the fifth channel, a flow of the preparation obtained at the second meeting point is established, by mixing the cell lysate with the precipitating agent; and (vi) a preparation comprising a supernatant containing the plasmid DNA and a precipitated or flocculated phase containing the majority of the cellular elements, including the genomic DNA, is recovered at the outlet of the fifth channel.
13. Procédé selon la revendication 12, dans lequel la longueur de la canalisation entre le premier et second point de rencontre est de l'ordre de 10 cm à quelques mètres.13. The method of claim 12, wherein the length of the pipe between the first and second meeting point is of the order of 10 cm to a few meters.
14. Procédé selon la revendication 11 , 12 ou 13, dans lequel l'agent précipitant et/ou neutralisant est de l'acétate de sodium ou de potassium.14. The method of claim 11, 12 or 13, wherein the precipitating and / or neutralizing agent is sodium or potassium acetate.
15. Procédé selon l'une des revendications 11 à 14, dans lequel (vii) on procède en outre à la séparation du surnageant d'avec la phase précipitée ou floculée, en continu de l'étape (vi) de récupération.15. Method according to one of claims 11 to 14, in which (vii) the supernatant is further separated from the precipitated or flocculated phase, continuously from step (vi) of recovery.
16. Procédé selon l'une des revendications 1 à 15, dans lequel les cellules sont des bactéries.16. Method according to one of claims 1 to 15, wherein the cells are bacteria.
17. Procédé selon l'une des revendications 1 à 15, dans lequel les cellules sont des cellules eucaryotes.17. Method according to one of claims 1 to 15, wherein the cells are eukaryotic cells.
18. Dispositif pour la mise en œuvre du procédé selon l'une des revendications 1 à 17, caractérisé en ce qu'il comporte, à partir d'une source de suspension cellulaire, telle qu'un réservoir, une canalisation permettant l'établissement d'un flux de suspension cellulaire, à partir d'une source d'un agent de lyse telle qu'un réservoir, une deuxième canalisation permettant l'établissement d'un flux de l'agent de lyse, lesdites première et deuxième canalisations aboutissant à 17 un premier point de rencontre dans lequel elles débouchent l'une dans l'autre, une troisième canalisation de petit diamètre et de longueur déterminée s'étendant à partir dudit premier point de rencontre, et des moyens pour l'établissement des flux dans lesdites première, deuxième et troisième canalisations ; la longueur, le diamètre et le débit dans ladite troisième canalisation étant adaptés de manière à obtenir un mélange sensiblement homogène aboutissant à un lysat sensiblement homogène.18. Device for implementing the method according to one of claims 1 to 17, characterized in that it comprises, from a source of cell suspension, such as a reservoir, a pipe allowing the establishment a flow of cell suspension, from a source of a lysis agent such as a reservoir, a second pipe allowing the establishment of a flow of the lysis agent, said first and second pipes ending at 17 a first meeting point into which they open into one another, a third pipe of small diameter and determined length extending from said first meeting point, and means for establishing the flows in said first, second and third pipelines; the length, the diameter and the flow rate in said third pipe being adapted so as to obtain a substantially homogeneous mixture resulting in a substantially homogeneous lysate.
19. Dispositif selon la revendication 18, caractérisé en ce qu'il comporte, en outre : à partir d'une source d'agent précipitant, telle qu'un réservoir, une quatrième canalisation aboutissant à un second point de rencontre à l'extrémité de ladite troisième canalisation de façon que les canalisations débouchent l'une dans l'autre, ladite troisième canalisation ayant une longueur déterminée par la distance entre ledit premier point de rencontre et ledit second point de rencontre, à partir dudit second point de rencontre, une cinquième canalisation de petit diamètre aboutissant à des moyens de récupération et/ou de séparation, et et des moyens pour l'établissement des flux dans lesdites quatrième et cinquième canalisations.19. Device according to claim 18, characterized in that it further comprises: from a source of precipitating agent, such as a reservoir, a fourth pipe leading to a second meeting point at the end of said third line so that the lines open into one another, said third line having a length determined by the distance between said first meeting point and said second meeting point, from said second meeting point, a fifth small diameter pipe leading to recovery and / or separation means, and and means for establishing the flows in said fourth and fifth pipes.
20. Dispositif selon la revendication 18 ou 19, dans lequel les moyens pour l'établissement des flux sont des moyens de pompage. 20. Device according to claim 18 or 19, in which the means for establishing the flows are pumping means.
PCT/FR1999/000105 1998-01-21 1999-01-20 Method and device for cell lysis WO1999037750A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU20604/99A AU756179B2 (en) 1998-01-21 1999-01-20 Method and device for cell lysis
EP99900963A EP1049766A1 (en) 1998-01-21 1999-01-20 Method and device for cell lysis
NZ505865A NZ505865A (en) 1998-01-21 1999-01-20 Method for cell lysis continuously producing a mixture of nucleated cells and lysing agent , the mixture flows in a steady stream through a tube having a diameter of 1cm or less
US09/600,664 US6664049B1 (en) 1999-01-20 1999-01-20 Method and device for cell lysis
CA002319021A CA2319021A1 (en) 1998-01-21 1999-01-20 Method and device for cell lysis
JP2000528658A JP2002500878A (en) 1998-01-21 1999-01-20 Method and apparatus for cell lysis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR98/00815 1998-01-21
FR9800815A FR2773818B1 (en) 1998-01-21 1998-01-21 BACTERIA LYSIS PROCESS AND DEVICE

Publications (1)

Publication Number Publication Date
WO1999037750A1 true WO1999037750A1 (en) 1999-07-29

Family

ID=9522178

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1999/000105 WO1999037750A1 (en) 1998-01-21 1999-01-20 Method and device for cell lysis

Country Status (7)

Country Link
EP (1) EP1049766A1 (en)
JP (1) JP2002500878A (en)
AU (1) AU756179B2 (en)
CA (1) CA2319021A1 (en)
FR (1) FR2773818B1 (en)
NZ (1) NZ505865A (en)
WO (1) WO1999037750A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001025482A1 (en) * 1999-10-02 2001-04-12 Bioneer Corporation Automatic dna purification apparatus
US6664049B1 (en) 1999-01-20 2003-12-16 Aventis Pasteur S.A. Method and device for cell lysis
KR100470803B1 (en) * 2002-09-25 2005-03-10 대한민국(관리부서:국립수산과학원) A rapid dna extraction method for pcr-based analysis of transgenic fish
WO2005026331A3 (en) * 2003-09-17 2005-11-17 Gencell Sas Method of preparation of pharmaceutically grade plasmid dna
WO2006029908A1 (en) * 2004-09-17 2006-03-23 Centelion Stable liquid formulations of plasmid dna
EP2088196A1 (en) 2008-02-08 2009-08-12 Boehringer Ingelheim RCV GmbH & Co KG Methods and devices for producing biomolecules
JP2010500042A (en) * 2006-08-15 2010-01-07 ビーエーエスエフ ソシエタス・ヨーロピア Method for protein isolation from producer cells
US8501402B2 (en) 2003-03-24 2013-08-06 Boehringer Ingelheim Rcv Gmbh & Co Kg Methods and devices for producing biomolecules
EP3594338A1 (en) 2018-07-12 2020-01-15 Kaneka Eurogentec SA Method and apparatus for the purification of extra-chromosomal nucleic acid sequences
CN111979109A (en) * 2020-09-01 2020-11-24 深圳普瑞金生物药业有限公司 Plasmid vector continuous cracking device
WO2021198281A1 (en) * 2020-03-31 2021-10-07 Richter-Helm Biologics Gmbh & Co. Kg Methods for producing plasmid dna

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005100542A1 (en) * 2004-04-19 2005-10-27 Centelion Method for purifying plasmid dna
DE102004052254A1 (en) * 2004-05-03 2005-12-01 Plasmid Factory Gmbh & Co. Kg Process for disrupting cells and separating cell components
ES2643944T3 (en) * 2007-01-12 2017-11-27 Dow Global Technologies Llc Apparatus and methods for applying an osmotic shock to cells
JP6113083B2 (en) * 2011-02-21 2017-04-19 リーアニクス・インコーポレイテッドRheonix, Inc. Nucleic acid purification method based on microfluidic device

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294824A (en) * 1975-08-05 1981-10-13 The Union International Company, Ltd. Extracts of the hemopoietic system
DE4028771A1 (en) * 1989-09-14 1991-02-21 Bert Sobolewski Stripping membrane coverings from parasites by shear force - developed during turbulent flow in restricted bore
US5096818A (en) * 1990-06-04 1992-03-17 Autogen Instruments, Inc. Nucleic acid separation method
WO1996002658A1 (en) * 1994-07-15 1996-02-01 Merck & Co., Inc. A method for large scale plasmid purification
WO1997023601A1 (en) * 1995-12-21 1997-07-03 Genzyme Corporation Method for lysing cells

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294824A (en) * 1975-08-05 1981-10-13 The Union International Company, Ltd. Extracts of the hemopoietic system
DE4028771A1 (en) * 1989-09-14 1991-02-21 Bert Sobolewski Stripping membrane coverings from parasites by shear force - developed during turbulent flow in restricted bore
US5096818A (en) * 1990-06-04 1992-03-17 Autogen Instruments, Inc. Nucleic acid separation method
WO1996002658A1 (en) * 1994-07-15 1996-02-01 Merck & Co., Inc. A method for large scale plasmid purification
WO1997023601A1 (en) * 1995-12-21 1997-07-03 Genzyme Corporation Method for lysing cells

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6664049B1 (en) 1999-01-20 2003-12-16 Aventis Pasteur S.A. Method and device for cell lysis
WO2001025482A1 (en) * 1999-10-02 2001-04-12 Bioneer Corporation Automatic dna purification apparatus
KR100470803B1 (en) * 2002-09-25 2005-03-10 대한민국(관리부서:국립수산과학원) A rapid dna extraction method for pcr-based analysis of transgenic fish
US8501402B2 (en) 2003-03-24 2013-08-06 Boehringer Ingelheim Rcv Gmbh & Co Kg Methods and devices for producing biomolecules
EP1664277B1 (en) * 2003-09-17 2011-11-09 Aventis Pharma S.A. Method of preparation of pharmaceutically grade plasmid dna
WO2005026331A3 (en) * 2003-09-17 2005-11-17 Gencell Sas Method of preparation of pharmaceutically grade plasmid dna
EA009447B1 (en) * 2003-09-17 2007-12-28 Сентельон Method of preparation of pharmaceutically grade plasmid dna
CN1882682B (en) * 2003-09-17 2010-06-16 森特利昂公司 Method of preparation of pharmaceutically grade plasmid DNA
WO2006029908A1 (en) * 2004-09-17 2006-03-23 Centelion Stable liquid formulations of plasmid dna
EA011554B1 (en) * 2004-09-17 2009-04-28 Сентелион Stable liquid formulations of plasmid dna
JP2010500042A (en) * 2006-08-15 2010-01-07 ビーエーエスエフ ソシエタス・ヨーロピア Method for protein isolation from producer cells
EP2088196A1 (en) 2008-02-08 2009-08-12 Boehringer Ingelheim RCV GmbH & Co KG Methods and devices for producing biomolecules
EP3594338A1 (en) 2018-07-12 2020-01-15 Kaneka Eurogentec SA Method and apparatus for the purification of extra-chromosomal nucleic acid sequences
WO2020011641A1 (en) 2018-07-12 2020-01-16 Kaneka Eurogentec S.A. Method and apparatus for the purification of extra-chromosomal nucleic acids sequences
EP4116417A1 (en) 2018-07-12 2023-01-11 Kaneka Eurogentec SA Method and apparatus for the purification of extra-chromosomal nucleic acids sequences
WO2021198281A1 (en) * 2020-03-31 2021-10-07 Richter-Helm Biologics Gmbh & Co. Kg Methods for producing plasmid dna
CN111979109A (en) * 2020-09-01 2020-11-24 深圳普瑞金生物药业有限公司 Plasmid vector continuous cracking device

Also Published As

Publication number Publication date
JP2002500878A (en) 2002-01-15
NZ505865A (en) 2002-12-20
FR2773818B1 (en) 2000-02-18
AU2060499A (en) 1999-08-09
FR2773818A1 (en) 1999-07-23
EP1049766A1 (en) 2000-11-08
CA2319021A1 (en) 1999-07-29
AU756179B2 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
EP1049766A1 (en) Method and device for cell lysis
CA2683354C (en) Method and device for purifying liquid effluents
CA2095070C (en) Rna amplification process requiring a single manipulation step
CA2742774C (en) Process for the ammonolysis of 11-bromoundecanoic acid
US6664049B1 (en) Method and device for cell lysis
CA2491164A1 (en) Method and apparatus for producing liposomes
Kim et al. Impact of physical and chemical cleaning agents on specific biofilm components and the implications for membrane biofouling management
WO2006030081A1 (en) Effluent treatment installation and clarification and filtration method using same
EP3268719A1 (en) Device for in-line monitoring of the quality of a water-soluble polymer solution manufactured from invert emulsion or powder of said polymer
FR2777293A1 (en) ELECTRO-SEPARATION PROCESS OF A BIOLOGICAL SAMPLE AND IMPLEMENTATION DEVICE
EP1819759A1 (en) Method and device for making polymer foam beads or balloons
CA2249465A1 (en) Purification of pharmaceutical-grade plasmid dna
WO2010081903A1 (en) Device for coating with a flocculating polymer material in the liquid state of ballast particles used for the treatment of water by ballasted flocculation, and corresponding facility
EP2633905A1 (en) Method and device for performing a polyphase chemical reaction
BE1029550B1 (en) AUTOMATED PLASMIDIC EXTRACTION
WO2013164554A1 (en) Method for recovering hydrocarbons from a sludge and device implementing such a method
WO2016059058A1 (en) Degumming method
WO2020136212A1 (en) Method and device for improving sludge biodegradability
WO2018065699A1 (en) Apparatus for controlling injection pressure for the assisted recovery of oil using polymer
EP0148072B1 (en) Process for the proteolysis of plasma proteins, and products obtained by this process
FR2598429A1 (en) Process and device for desalination of a liquid hydrocarbon feedstock, especially of crude oil
BE1028063A1 (en) HYALURONIC ACID PURIFICATION METHOD
BE1030362A1 (en) AUTOMATED PERIPLASMIC EXTRACTION
TavakoliNaeini Large Scale Production, Purification, and Modification of Chitosan-Based Complexes for Gene Therapy
WO2004072292A1 (en) Method and device for the continuous production of biomolecules

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 20604/99

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 505865

Country of ref document: NZ

ENP Entry into the national phase

Ref document number: 2319021

Country of ref document: CA

Ref country code: CA

Ref document number: 2319021

Kind code of ref document: A

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 1999900963

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999900963

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 09600664

Country of ref document: US

WWG Wipo information: grant in national office

Ref document number: 20604/99

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 1999900963

Country of ref document: EP